| 中文摘要 |
因應國際間政經動向及全球化發展,許多國家於貿易自由化之進程中,致力參與多邊經貿談判,以加速與國際接軌。本文先簡介國際間高度關注,分別由日本、中國、美國所主導之「跨太平洋夥伴全面進步協定(Comprehensive and Progressive Agreement for Trans-Pacific Partnership, CPTPP)」、「區域全面經濟夥伴協定(Regional Comprehensive Economic Partnership, RCEP)」及「印太經濟架構(Indo-Pacific Economic Framework, IPEF)」區域經濟整合協定,進一步分析CPTPP條文中與食藥醫粧法規相對應之內容,顯示我國可符合CPTPP高標準規範。我國多年來致力爭取加入各區域經濟整合協定,衛生福利部食品藥物管理署應持續關注相關動態,以有所因應準備。 |
| 英文摘要 |
In response to trends of international political and economic development and globalization, many countries are devoted to participating in multilateral economic and trade negotiations, in order to integrate with international standards. In the beginning of this article, we made a brief introduction on three highly international concerned regional trade agreements, Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), Regional Comprehensive Economic Partnership (RCEP) and Indo- Pacific Economic Framework (IPEF), which are led by Japan, China, and the United States, respectively. Taiwan has already officially applied to join CPTPP in 2021. Further analysis on the text of CPTPP and the domestic laws or regulations of food, drugs, medical devices and cosmetics operations, showed that Taiwan could meet the high standards of CPTPP. Taiwan has always been striving to join the international regional trade agreements so that Taiwan Food and Drug Administration should keep following international trade relevant information to be well-prepared before any task comes. |